Profil
Hayley Patricia French currently works at Domainex Ltd., as Chief Executive Officer from 2025, Apitope International NV, as Chief Operating Officer & Director, and Vesalius Biocapital Partners SARL, as Venture Partner from 2022.
Dr. French also formerly worked at Bird & Bird LLP, as Principal, Health Protection Agency, as Head-Commercial Legal Affairs, Novartis Pharma NV, as Principal, and Licensing Executives Society Britain & Ireland, as President.
Dr. French received her undergraduate degree from The University of Liverpool and graduate degree and doctorate degree from Queen Mary University of London.
Postes actifs de Hayley French
| Sociétés | Poste | Début |
|---|---|---|
Apitope International NV
Apitope International NV BiotechnologyHealth Technology Develops therapeutic vaccines | Directeur des opérations | 01/11/2010 |
Vesalius Biocapital Partners SARL
Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners invests in companies located in Europe. The firm targets companies operating in the fields of life science, therapeutics, medical devices and diagnostics sectors. It provides financing for seed, early and later stage capital requirements with an investment size of up to USD 10 million. It acts as a lead & co-investor and acquires majority interest and also takes a seat on the board of directors. | Private Equity Investor | 01/03/2022 |
Domainex Ltd.
Domainex Ltd. BiotechnologyHealth Technology Operates as a drug discovery company | Directeur Général | 07/05/2025 |
Anciens postes connus de Hayley French
| Sociétés | Poste | Fin |
|---|---|---|
Licensing Executives Society Britain & Ireland | President | - |
Bird & Bird LLP
Bird & Bird LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Corporate Officer/Principal | - |
Health Protection Agency
Health Protection Agency General GovernmentGovernment Governmental department | Conseiller Juridique Général | - |
Novartis Pharma NV
Novartis Pharma NV Pharmaceuticals: MajorHealth Technology Develops medicines | Corporate Officer/Principal | - |
Formation de Hayley French
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bird & Bird LLP
Bird & Bird LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Commercial Services |
Health Protection Agency
Health Protection Agency General GovernmentGovernment Governmental department | Government |
Novartis Pharma NV
Novartis Pharma NV Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
Domainex Ltd.
Domainex Ltd. BiotechnologyHealth Technology Operates as a drug discovery company | Health Technology |
Vesalius Biocapital Partners SARL
Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners invests in companies located in Europe. The firm targets companies operating in the fields of life science, therapeutics, medical devices and diagnostics sectors. It provides financing for seed, early and later stage capital requirements with an investment size of up to USD 10 million. It acts as a lead & co-investor and acquires majority interest and also takes a seat on the board of directors. | Finance |
Apitope International NV
Apitope International NV BiotechnologyHealth Technology Develops therapeutic vaccines | Health Technology |
Queen Mary University of London
Queen Mary University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Licensing Executives Society Britain & Ireland |
















